Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05600283 · ClinicalTrials.gov registry record · NA
Patient Self-sampling of HPV to Screen for Cervical Cancer
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
NCT05600283: Completed NA study, sponsored by Mayo Clinic.
NCT05600283 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 222 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05600283, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
Study Summary
The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.
Interventions
- DIAGNOSTIC_TEST Swab kit (COBAS HPV 4800 Assay -Evalyn brush)
- DIAGNOSTIC_TEST Clinician-collection of cervical sample for HPV testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2024-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05600283
The ClinicalTrials.gov registry entry for NCT05600283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Swab kit (COBAS HPV 4800 Assay -Evalyn brush) is the first listed.
NCT05600283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05600283 about?
NCT05600283 is a clinical study titled "Patient Self-sampling of HPV to Screen for Cervical Cancer". The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cerv...
What is the current status of trial NCT05600283?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2022-11-16. Estimated completion is 2024-06-04.
What interventions are being tested in trial NCT05600283?
The interventions under investigation include: Swab kit (COBAS HPV 4800 Assay -Evalyn brush) (DIAGNOSTIC_TEST), Clinician-collection of cervical sample for HPV testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05600283?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.